1/23
05:06 am
ibrx
Rating for IBRX
High
Report
Rating for IBRX
1/22
07:02 pm
ibrx
ImmunityBio (NASDAQ:IBRX) had its "buy" rating reaffirmed by analysts at BTIG Research.
High
Report
ImmunityBio (NASDAQ:IBRX) had its "buy" rating reaffirmed by analysts at BTIG Research.
12/12
01:57 pm
ibrx
Rating for IBRX
Low
Report
Rating for IBRX
12/12
01:57 pm
ibrx
Rating for IBRX
Low
Report
Rating for IBRX